CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment of immune‐related bowel disease
暂无分享,去创建一个
Minhu Chen | Z. Zeng | Shenghong Zhang | Baili Chen | Yao He | R. Mao | Y. Qiu | P-P Xu | R. Feng
暂无分享,去创建一个
Minhu Chen | Z. Zeng | Shenghong Zhang | Baili Chen | Yao He | R. Mao | Y. Qiu | P-P Xu | R. Feng